Results 181 to 190 of about 67,544 (271)

Evaluation of High-Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins During Reverse Remnant-Cholesterol Transport in Familial Hypercholesterolemia. [PDF]

Endocrinol Diabetes Metab
Ganjali S, de Haan JB, Le Goff W, Kontush A, Sahebkar A.   +4 more
europepmc   +1 more source

Beyond Immunity: Functional Outcomes of Dietary Yeast and Seaweed β‐Glucans in Adult Canine Nutrition

Journal of Animal Physiology and Animal Nutrition, Volume 110, Issue 5, Page 609-623, September 2026.
ABSTRACT β‐Glucans are functional compounds associated with health benefits; however, the physiological effects of different β‐glucan sources in dog foods remain incompletely understood. This study evaluated and compared the effects of β‐glucans derived from Euglena gracilis (seaweed) and Saccharomyces cerevisiae (yeast) on nutrient digestibility ...
Stephanie de Souza Theodoro, Maria Eduarda Gonçalves Tozato, Letícia Warde Luis, Camila Goloni, Jhennifer de Castro Fenerick, Lucas Bassi Scarpim, Isabel Ten Caten Bento, Connie Abril Rojas, Marcelino Bortolo, Aulus Cavalieri Carciofi   +9 more
wiley   +1 more source

High lipoprotein(a) results in overestimation of BQ-based low-density lipoprotein-cholesterol measurement. [PDF]

J Lipid Res
Yamazaki A, Hakii Y, Ai M, Miyake S, Takahashi J, Yoshimoto A, Kameda T, Ichimura N, Tohda S, Yokoyama S, Ohkawa R.   +10 more
europepmc   +1 more source

Autophagy in MASLD: A Metabolic and Precision Medicine Perspective

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver condition worldwide and a major contributor to cirrhosis and hepatocellular carcinoma (HCC). While metabolic triggers such as obesity and insulin resistance are key drivers of MASLD, growing evidence has identified defects in intracellular quality
Alessandra Cazzaniga, Silvia Frigo, Alessandro Cherubini, Eniada Rrapaj, Luca Valenti   +4 more
wiley   +1 more source

Interaction between the number of KIV2 repeats and the cholesterol content of an Lp(a) particle: What to do with these novel data? [PDF]

J Lipid Res
Reyes-Soffer G, Ginsberg HN.
europepmc   +1 more source

Liver Fat Changes in Patients With Type 2 Diabetes by Presence of Genetic Hepatic Steatosis: A Post Hoc Analysis of SURPASS‐3 MRI

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT The patatin‐like phospholipase 3 (PNPLA3) I148M genetic variant is highly associated with steatotic liver disease. In the SURPASS‐3 MRI substudy, tirzepatide significantly reduced liver fat content (LFC) versus insulin degludec in insulin‐naïve patients with type 2 diabetes with metabolic dysfunction‐associated steatotic liver disease.
Kenneth Cusi, Amalia Gastaldelli, Laura Fernández Landó, Palash Sharma, Amelia Torcello‐Gómez, Ángel Rodríguez   +5 more
wiley   +1 more source

Molecular Mechanism of Absorption, Transport and Metabolic Transformation of Astaxanthin in Aquatic Animals

Reviews in Aquaculture, Volume 18, Issue 4, September 2026.
This manuscript systematically elucidates the molecular mechanisms underlying absorption, transport, and metabolism of Astaxanthin in aquatic animals, through the analysis of biological functions, transport proteins, and enzyme metabolism system. Furthermore, it outlines future molecular research strategies for Astaxanthin, providing a theoretical ...
Huakang Peng, Yihui Du, Qianwen Ding, Dongdong Du, Ruyue Dong, Chao Ran, Zhen Zhang, Yuanyuan Yao, Hui Liang, Ming Li, Nan Wang, Yalin Yang, Zhigang Zhou   +12 more
wiley   +1 more source

Metabolomic signature reveals dysregulated lipoprotein profile in m.3243A>G carriers: a case-control study. [PDF]

Metabolomics
Nielsen SR, Nguyen HTT, Stoico MP, Brock C, Højlund K, Pedersen IS, Frederiksen AL.   +6 more
europepmc   +1 more source

FAHFAs are detected in postprandial chylomicron and VLDL fractions and can be released from TG estolides by LPL in vitro. [PDF]

J Lipid Res
Milonaityte D, Brejchova K, Srp J, Kudova E, Chodounska H, Balas L, Durand T, Abumrad NA, Kuda O.   +8 more
europepmc   +1 more source

Century of Progress on the Structure of APOB-100 in Atherogenic Lipoproteins. [PDF]

Circ Res
Coleman B, Woollett LA, Davidson WS.
europepmc   +1 more source